Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic nerve in a phase 2 study. The ACUITY trial in France analyzed 33 patients who ...

A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The researchers behind the study have now started a clinical trial on patients. A ...

A deep-learning model trained on optical coherence tomography scans of the optic nerve head reliably distinguished among various types of optic nerve damage, such as glaucoma, non-arteritic anterior ...

New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...